You are here: Industry Insights > Artificial Intelligence

News List

Innovative Strategies to Accelerate Drug R&D, and Regulatory Approvals Saher Haider
October 15, 2024
Global health crises, with the COVID-19 pandemic being the most predominant one, revealed the importance and the stark inefficiencies of traditional drug development pathways.
The Transformative Role of Generative AI (genAI) in the Pharmaceutical Industry David Orchard-Webb
April 01, 2024
The future of genAI in pharmaceuticals is bright, promising a healthier, more efficient approach to drug development and patient care.
Artificial Intelligence for Drug Development David Orchard-Webb
July 31, 2023
Artificial Intelligence (AI) is making a significant impact in the pharmaceutical industry, revolutionizing various aspects of drug discovery, development, and healthcare.
Latest Trends in Pharmaceutical Industry Muhammad Asim Niazi
June 14, 2023
Recent years have seen innovation in many fields, such as software and computing.For the pharmaceutical industry, these latest trends have changed the paradigm of every field.
Artificial Intelligence and COVID-19 Vaccines Lin Zhang
May 31, 2021
In recent years, AI, in general, is becoming a popular tool in the pharmaceutical industry, not just in the case of COVID specifically.
Pharma and Health from Ingredients to Pills: Artificial Intelligence (AI) and Drug Development Lin Zhang
December 09, 2020
Artificial Intelligence (AI) is gaining traction across a variety of sectors. AI can be used for a variety of goals and is likely to become a staple in drug development, among other things.
How AI is Redefining the Pharmaceutical Industry in China Neeta Ratanghayra
October 22, 2020
Artificial intelligence (AI) refers to the use of automated algorithms to perform the tasks conventionally done with human intelligence.
Navigo Proteins and Nostrum Biodiscovery Announce a Research Collaboration to Enhance Affilin® Ligand Discovery Using Cutting-Edge AI and Molecular Modeling Techniques B3C newswire
November 06, 2023
We are excited to announce a pioneering partnership between Nostrum Biodiscovery, a frontrunner in computational molecular engineering services, and Navigo Proteins, an innovator developing next generation targeting ligands called Affilin®.
Artificial intelligence could be new blueprint for precision drug discovery worldpharmanews
July 13, 2021
Writing in the July 12, 2021 online issue of Nature Communications, researchers at University of California San Diego School of Medicine describe a new approach that uses machine learning to hunt for disease targets and then predicts whether a drug is ...
The five biggest data challenges for life sciences expresspharma
April 06, 2021
The life sciences industry is at a turning point. To prepare for the future and remain relevant in the ever-evolving business landscape, biopharma companies and medical technology businesses are looking for new ways to create value and make sense of ...

Previous page 1 2 3 4 5 6 Next page